论文信息 - FEASIBILITY AND EFFICACY OF DOSE ADJUSTED MELPHALAN - PREDNISONE - BORTEZOMIB IN PATIENTS >= 75 YEARS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; PRELIMINARY RESULTS OF THE PHASE II HOVON 123 STUDY - 字舞流文

FEASIBILITY AND EFFICACY OF DOSE ADJUSTED MELPHALAN - PREDNISONE - BORTEZOMIB IN PATIENTS >= 75 YEARS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; PRELIMINARY RESULTS OF THE PHASE II HOVON 123 STUDY

K. Nasserinejad | P. Sonneveld | C. Eeltink | M. Minnema | M. Levin | S. Klein | P. Ypma | S. Zweegman | B. Tanis | H. Visser-Wisselaar | M. Slee-Valentijn | W. Deenik | M. Westerman | C. Stege | N. V. D. Donk | Amanda C. Dijk | E. D. Waal